<table id="id_bd3bcee4-1cc1-45dd-9974-e383643b7f9a" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_cd90da41-613e-49d9-9580-347913f96681">Table I. Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.<sup>¶</sup>
</caption>
<col></col>
<col></col>
<col></col>
<thead>
<tr id="id_fc371426-aa00-4885-a8c4-19f502840b0f" stylecode="Botrule">
<td align="left" stylecode="Rrule" valign="bottom">Population Characteristics</td>
<td align="left" stylecode="Rrule" valign="top">Total body clearance*<br/>mean (range) <sup>††</sup>
<br/>(mL/kg/min)</td>
<td align="left" valign="top">Half-life<br/>Mean (range) <sup>††</sup>
<br/>(hr)</td>
</tr>
</thead>
<tfoot id="id_c0077938-507f-4668-a6ff-65805d51ba81">
<tr>
<td align="left" colspan="3" valign="top">
<sup>¶</sup> For various North American patient populations from literature reports. Different rates of elimination and consequent dosage requirements have been observed among other peoples.</td>
</tr>
<tr>
<td align="left" colspan="3" valign="top">* Clearance represents the volume of blood completely cleared of theophylline by the liver in one minute. Values listed were generally determined at serum theophylline concentrations &lt;20 mcg/mL; clearance may decrease and half-life may increase at higher serum concentrations due to non-linear pharmacokinetics. </td>
</tr>
<tr>
<td align="left" colspan="3" valign="top">
<sup>††</sup> Reported range or estimated range (mean ± 2 SD) where actual range not reported.</td>
</tr>
<tr>
<td align="left" colspan="3" valign="top">
<sup>†</sup> NR =not reported or not reported in a comparable format.</td>
</tr>
<tr>
<td align="left" colspan="3" valign="top">** Median</td>
</tr>
<tr>
<td align="left" colspan="3" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="3" valign="top">
<content stylecode="underline">
<content stylecode="bold">Note:</content>
</content> In addition to the factors listed above, theophylline clearance is increased and half-life decreased by low carbohydrate/high protein diets, parenteral nutrition, and daily consumption of charcoal-broiled beef. A high carbohydrate/low protein diet can decrease the clearance and prolong the half-life of theophylline.</td>
</tr>
</tfoot>
<tbody>
<tr id="id_b8c98a93-8198-4c3b-a29c-527a0d9e6130" stylecode="Toprule">
<td align="left" stylecode="Botrule Toprule Rrule" valign="top">
<content stylecode="underline">Age</content>
</td>
<td align="left" stylecode="Toprule" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_a2cfb0cc-7072-4dee-a717-153787730f11">
<td align="left" valign="top">Premature neonates</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_be6ee170-d7cd-4e2e-b014-6217b794b233">
<td align="left" valign="top">   postnatal age 3-15 days</td>
<td align="left" valign="top">0.29 (0.09-0.49)</td>
<td align="left" valign="top">30 (17-43)</td>
</tr>
<tr id="id_10ee7fc7-ac15-41ef-9860-ec5b1e19da83">
<td align="left" valign="top">   postnatal age 25-57 days</td>
<td align="left" valign="top">0.64 (0.04-1.2)</td>
<td align="left" valign="top">20 (9.4-30.6)</td>
</tr>
<tr id="id_b2856b84-6bed-4408-940f-d8be1f7a39a9">
<td align="left" valign="top">Term infants</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_8b3a32cd-47d0-4fba-90e1-e60149a12716">
<td align="left" valign="top">   postnatal age 1-2 days</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
<td align="left" valign="top">25.7 (25-26.5)</td>
</tr>
<tr id="id_a39a6b59-2f37-4277-9c3c-865fee19d47b">
<td align="left" valign="top">   postnatal age 3-30 weeks</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
<td align="left" valign="top">11 (6-29)</td>
</tr>
<tr id="id_77dafe4e-d54b-4b6c-a6ef-32755f723dce">
<td align="left" valign="top">Children</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_dac1e1e6-252d-41b2-a42e-6dd901e922f2">
<td align="left" valign="top">   1-4 years</td>
<td align="left" valign="top">1.7 (0.5-2.9)</td>
<td align="left" valign="top">3.4 (1.2-5.6)</td>
</tr>
<tr id="id_2e22b790-5d89-4dfc-9ced-3550806c579a">
<td align="left" valign="top">   4-12 years </td>
<td align="left" valign="top">1.6 (0.8-2.4)</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
</tr>
<tr id="id_2b5f59c2-3a27-4b99-8f17-05b3024aab42">
<td align="left" valign="top">   13-15 years</td>
<td align="left" valign="top">0.9 (0.48-1.3) </td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
</tr>
<tr id="id_160c007c-ab38-4c0f-b92a-102b701cdb2a">
<td align="left" valign="top">   6-17 years </td>
<td align="left" valign="top">1.4 (0.2-2.6)</td>
<td align="left" valign="top">3.7 (1.5-5.9)</td>
</tr>
<tr id="id_4c72b21b-c6e8-4fec-808c-4b23badf674d">
<td align="left" valign="top">Adults (16-60 years)</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_5b92805d-1ad1-4263-a05d-a91735dba503">
<td align="left" valign="top">   otherwise healthy</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_dc6d5bdf-5ff0-498e-92f4-e0594bb09102">
<td align="left" valign="top">   non-smoking asthmatics</td>
<td align="left" valign="top">0.65 (0.27-1.03) </td>
<td align="left" valign="top">8.7 (6.1-12.8)</td>
</tr>
<tr id="id_6bbe9b56-9254-4747-aebc-c3366e783d39">
<td align="left" valign="top">Elderly (&gt;60 years) </td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_c3d54372-40fd-479a-ac00-acb792ad0d74">
<td align="left" valign="top">   non-smokers with normal cardiac,</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_6527b0f3-8dee-4c57-ad34-02e37270ad00">
<td align="left" valign="top">   liver, and renal function</td>
<td align="left" valign="top">0.41 (0.21-0.61)</td>
<td align="left" valign="top">9.8 (1.6-18)</td>
</tr>
<tr id="id_7f509b5b-2b8d-4fd0-9607-c876000929ed">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="underline">Concurrent illness or altered physiological state</content>
</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_41e8852d-93d0-441d-9a9a-ced1b8067703">
<td align="left" valign="top">Acute pulmonary edema</td>
<td align="left" valign="top">0.33**(0.07-2.45)</td>
<td align="left" valign="top">19**(3.1-82)</td>
</tr>
<tr id="id_61436d1b-f99f-4c05-98bf-1c3ecbccfec9">
<td align="left" valign="top">COPD &gt;60 years, stable non-smoker &gt;1 year</td>
<td align="left" valign="top">0.54 (0.44-0.64) </td>
<td align="left" valign="top">11 (9.4-12.6)</td>
</tr>
<tr id="id_883a7b35-c947-4918-8ad3-75c4c613e24a">
<td align="left" valign="top">COPD with cor-pulmonale </td>
<td align="left" valign="top">0.48 (0.08-0.88)</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
</tr>
<tr id="id_536d47de-ee57-4157-a7a6-1ab287732064">
<td align="left" valign="top">Cystic fibrosis (14-28 years)</td>
<td align="left" valign="top">1.25 (0.31-2.2)</td>
<td align="left" valign="top">6.0 (1.8-10.2)</td>
</tr>
<tr id="id_94c5dafd-c459-4f1f-bc12-7a0cd43b68ab">
<td align="left" valign="top">Fever associated with acute viral</td>
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
</tr>
<tr id="id_7f8a636b-b115-4060-9c99-d9fe0cbcf602">
<td align="left" valign="top">   respiratory illness (children 9-15 years)</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
<td align="left" valign="top">7.0 (1.0-13)</td>
</tr>
<tr id="id_03fecec5-7c01-43c3-a426-c8018f7a7993">
<td align="left" valign="top">Liver disease – cirrhosis</td>
<td align="left" valign="top">0.31**(0.1-0.7)</td>
<td align="left" valign="top">32**(10-56)</td>
</tr>
<tr id="id_1b97512e-42e6-4a41-8589-a5d7723ea85b">
<td align="left" valign="top">                       acute hepatitis</td>
<td align="left" valign="top">0.35 (0.25-0.45) </td>
<td align="left" valign="top">19.2 (16.6-21.8)</td>
</tr>
<tr id="id_952dc549-f982-48f2-95a5-94f1ae172e7a">
<td align="left" valign="top">                       cholestasis</td>
<td align="left" valign="top">0.65 (0.25-1.45) </td>
<td align="left" valign="top">14.4 (5.7-31.8)</td>
</tr>
<tr id="id_bc96e4c8-b0fb-4856-a8b0-c3d525d039ab">
<td align="left" valign="top">Pregnancy – 1<sup>st</sup> trimester</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
<td align="left" valign="top">8.5 (3.1-13.9)</td>
</tr>
<tr id="id_a157e68c-70a8-4517-9e94-fbf4ece3da4e">
<td align="left" valign="top">                   2<sup>nd</sup> trimester</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
<td align="left" valign="top">8.8 (3.8-13.8)</td>
</tr>
<tr id="id_914c04ed-f1ba-437c-b3df-61602846d428">
<td align="left" valign="top">                   3<sup>rd</sup> trimester</td>
<td align="left" valign="top">NR <sup>†</sup>
</td>
<td align="left" valign="top">13.0 (8.4-17.6)</td>
</tr>
<tr id="id_5033bdec-f449-459d-9741-1fcbaf6b4a39">
<td align="left" valign="top">Sepsis with multi-organ failure </td>
<td align="left" valign="top">0.47 (0.19-1.9) </td>
<td align="left" valign="top">18.8 (6.3-24.1)</td>
</tr>
<tr id="id_0ef0dd54-aec2-4e22-8555-4a9aa2cbaa6d">
<td align="left" valign="top">Thyroid disease – hypothyroid</td>
<td align="left" valign="top">0.38 (0.13-0.57) </td>
<td align="left" valign="top">11.6 (8.2-25)</td>
</tr>
<tr id="id_b4dfdbee-3346-4c79-af48-f64f2259e426">
<td align="left" valign="top">                           hyperthyroid </td>
<td align="left" valign="top">0.8 (0.68-0.97) </td>
<td align="left" valign="top">4.5 (3.7-5.6)</td>
</tr>
</tbody>
</table>